VIM and cancer: Since cancer cells need to survive even in the absence of proper cell adhesion in the bloodstream during their journey to distant metastatic sites, we hypothesized that the survival benefits of vimentin may reduce programmed cell death of cancer cells, or anoikis, caused by the absence of adhesion [25, 26].